Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure

ALKIS N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., ...More

JOURNAL OF BUON, vol.16, no.1, pp.80-83, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 1
  • Publication Date: 2011
  • Title of Journal : JOURNAL OF BUON
  • Page Numbers: pp.80-83


Purpose: To retrospectively evaluate the efficacy and tolerability of mitomycin-C (MMC) in combination with fluoropyrimidines as salvage 3rd -or 4th-line therapy in metastatic colorectal cancer (MCRC) patients.